UP!

News

Cardinal Health, Inc. -1.06% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2021 2021-02-04 Future report Set alerts
Q1 2021 2020-11-05 Future report Set alerts
Q4 2020 2020-08-06 1.04 2.23
Q3 2020 2020-05-11 1.62 1.19
Q2 2020 2020-02-06 1.52 0.75
Q1 2020 2019-11-07 1.27 -16.65
Q4 2019 2019-08-08 1.11 0.65
Q3 2019 2019-05-09 1.59 0.99
Q2 2019 2019-02-07 1.29 0.93
Q1 2019 2018-11-08 1.29 1.94

Ratings

2016-07-06 Reiterated Rating Goldman Sachs Group Inc. Buy
2016-06-20 Reiterated Rating Leerink Swann Outperform $92.00
2016-06-20 Reiterated Rating FBR & Co. Buy
2016-06-20 Reiterated Rating FBR & Co Buy
2016-06-15 Reiterated Rating Morgan Stanley Hold
2016-06-13 Reiterated Rating RBC Capital Buy
2016-06-13 Reiterated Rating Royal Bank Of Canada Buy
2016-06-08 Initiated Coverage Bank of America Hold
2016-06-08 Initiated Coverage Bank of America Corp. Hold
2016-06-07 Reiterated Rating Bank of America Neutral
2016-06-01 Downgrade Raymond James Outperform to Market Perform
2016-06-01 Downgrade Raymond James Financial Inc. Outperform to Market Perform
2016-05-02 Reiterated Rating Leerink Swann Buy
2016-04-18 Initiated Coverage Avondale Partners Outperform $111.00
2016-04-15 Reiterated Rating Goldman Sachs Buy $105.00
2016-04-15 Reiterated Rating Goldman Sachs Group Inc. Buy $105.00
2016-04-02 Reiterated Rating Deutsche Bank Hold
2016-04-02 Reiterated Rating Deutsche Bank AG Hold
2016-03-15 Downgrade Cowen and Company Outperform to Market Perform $99.00 to $90.00
2016-03-15 Initiated Coverage Credit Suisse Outperform $102.00
2016-03-15 Initiated Coverage Credit Suisse Group AG Outperform $102.00
2016-03-07 Upgrade Goldman Sachs Buy to Conviction-Buy
2016-02-11 Lower Price Target RBC Capital Outperform $105.00 to $95.00
2016-02-02 Reiterated Rating FBR & Co. Outperform $100.00
2016-02-02 Reiterated Rating William Blair Outperform
2016-02-02 Reiterated Rating RBC Capital Outperform $105.00
2016-01-12 Reiterated Rating Robert W. Baird Outperform $110.00 to $107.00
2016-01-06 Downgrade Raymond James Outperform to Market Perform
2015-12-17 Upgrade FBR & Co. Underperform to Market Perform
2015-12-17 Upgrade Goldman Sachs Neutral to Buy $93.00 to $100.00
2015-11-22 Initiated Coverage William Blair Buy
2015-11-04 Reiterated Rating Leerink Swann Buy $100.00 to $105.00
2015-11-03 Boost Price Target Barclays Overweight $92.00 to $98.00
2015-11-03 Boost Price Target Deutsche Bank Neutral to Hold $91.00 to $100.00
2015-11-03 Boost Price Target RBC Capital Outperform $92.00 to $95.00
2015-11-03 Lower Price Target FBR & Co. Outperform $100.00 to $97.00
2015-11-03 Boost Price Target Barclays PLC Overweight $92.00 to $98.00
2015-10-21 Boost Price Target Cowen and Company $100.00 to $102.00
2015-08-26 Reiterated Rating William Blair Buy
2015-07-14 Downgrade Evercore ISI Buy to Hold $91.50
2015-06-08 Boost Price Target Leerink Swann Outperform $94.00 to $100.00
2015-06-05 Reiterated Rating Deutsche Bank Hold $91.00 to $93.00
2015-03-10 Boost Price Target FBR & Co. Outperform $92.00 to $97.00
2015-03-04 Boost Price Target RBC Capital Outperform $96.00 to $107.00
2015-03-03 Boost Price Target Deutsche Bank Hold $87.00 to $91.00
2015-03-03 Boost Price Target Argus Buy $90.00 to $105.00
2015-03-02 Reiterated Rating Citigroup Inc. Hold
2015-03-02 Boost Price Target Mizuho Buy $93.00 to $103.00
2015-02-02 Downgrade Morgan Stanley Overweight to Equal Weight $86.00
2015-01-30 Boost Price Target Barclays Overweight $90.00 to $92.00
2015-01-30 Reiterated Rating Citigroup Inc. Hold $89.00 to $91.00
2015-01-30 Reiterated Rating Deutsche Bank Hold $78.00 to $87.00
2015-01-30 Boost Price Target RBC Capital Outperform $90.00 to $96.00
2015-01-30 Boost Price Target Mizuho Buy $87.00 to $93.00
2015-01-29 Boost Price Target FBR & Co. Outperform $85.00 to $92.00
2015-01-28 Downgrade Morgan Stanley Overweight to Equal Weight $86.00
2015-01-08 Boost Price Target Barclays Overweight $84.00 to $90.00
2015-01-08 Reiterated Rating JPMorgan Chase & Co. Hold $75.00 to $85.00
2014-12-29 Set Price Target Bank of America Buy $86.00 to $90.00
2014-11-05 Boost Price Target Argus Buy $83.00 to $90.00
2014-10-31 Reiterated Rating Barclays Overweight $82.00 to $84.00
2014-10-31 Reiterated Rating FBR & Co. Outperform $77.00 to $85.00
2014-10-31 Reiterated Rating Credit Suisse Outperform $80.00 to $88.00
2014-10-31 Reiterated Rating Citigroup Inc. Neutral $75.00 to $83.00
2014-10-31 Reiterated Rating Deutsche Bank Hold $72.00 to $78.00
2014-10-31 Boost Price Target Mizuho Buy $77.00 to $87.00
2014-10-16 Initiated Coverage RBC Capital Outperform $90.00
2014-08-18 Reiterated Rating Argus Buy $83.00 to $71.43
2014-08-05 Reiterated Rating Barclays Overweight $77.00 to $82.00
2014-08-05 Reiterated Rating Credit Suisse Outperform $76.00 to $80.00
2014-08-05 Boost Price Target Leerink Swann Outperform $78.00 to $84.00
2014-08-04 Reiterated ISI Group Buy $77 to $78.50
2014-08-04 Reiterated Rating Mizuho Buy
2014-08-04 Boost Price Target Evercore ISI Buy $77.00 to $78.50
2014-07-09 Boost Price Target Robert W. Baird $80.00 to $82.00
2014-06-02 Reiterated Rating Morgan Stanley Overweight $76.00
2014-05-21 Reiterated Rating Morgan Stanley Overweight $76.00
2014-05-05 Lower Price Target Credit Suisse Outperform $80.00 to $76.00
2014-05-02 Reiterated Rating Barclays Overweight $77.00
2014-05-02 Lower Price Target Mizuho $79.00 to $77.00
2014-05-02 Lower Price Target Cowen and Company $85.00 to $82.00
2014-05-02 Lower Price Target Raymond James $77.00 to $75.00
2014-04-03 Reiterated Rating Bank of America Buy $75.00 to $76.00
2014-03-24 Boost Price Target Cowen and Company $83.00 to $85.00
2014-03-10 Upgrade Ned Davis Research Neutral to Buy
2014-03-05 Initiated Coverage Barclays Overweight $79.00
2014-03-04 Boost Price Target Deutsche Bank $66.00 to $72.00
2014-02-18 Initiated Coverage Citigroup Inc. Neutral
2014-01-31 Reiterated FBR Capital Outperform $72 to $78
2014-01-31 Boost Price Target Sterne Agee CRT $73.00 to $83.00
2014-01-31 Boost Price Target Raymond James $75.00 to $77.00
2014-01-31 Boost Price Target FBR & Co. Outperform $72.00 to $78.00
2014-01-08 Downgrade JPMorgan Chase & Co. Overweight to Neutral $75.00
2013-12-11 Reiterated ISI Group Buy $65.50 to $73.50
2013-12-11 Reiterated FBR Capital Outperform $68 to $72
2013-12-11 Boost Price Target Evercore ISI Buy $65.50 to $73.50
2013-12-11 Upgrade Leerink Swann Market Perform to Outperform $60.00 to $75.00
2013-12-11 Boost Price Target FBR & Co. Outperform $68.00 to $72.00
2013-12-09 Boost Price Target Mizuho Buy $65.00 to $76.00
2013-11-20 Initiated Coverage Deutsche Bank Hold $66.00
2013-11-06 Upgrade Sterne Agee CRT Neutral to Buy $59.00 to $73.00
2013-11-05 Boost Price Target Argus Buy $65.00 to $73.00
2013-11-01 Boost Price Target Cowen and Company Outperform $60.00 to $68.00
2013-11-01 Boost Price Target Mizuho Buy $56.00 to $65.00
2013-10-29 Initiated Coverage FBR & Co. Outperform $64.00
2013-10-14 Boost Price Target Evercore ISI Buy $56.00 to $62.00
2013-10-07 Boost Price Target Robert W. Baird Outperform $60.00 to $64.00
2013-10-03 Boost Price Target Credit Suisse Outperform $58.00 to $60.00
2013-09-19 Initiated Coverage Sterne Agee CRT Neutral $48.00
2013-08-06
2013-08-02 Reiterated ISI Group Buy $50 to $56
2013-07-01 Reiterated Mizuho Buy $51 to $53
2013-05-02 Reiterated ISI Group Buy $47.50 to $50
2013-03-07 Reiterated Mizuho Buy $49 to $51
2016-07-06 Reiterated Rating Goldman Sachs Group Inc. Buy
2016-06-20 Reiterated Rating Leerink Swann Outperform $92.00
2016-06-20 Reiterated Rating FBR & Co. Buy
2016-06-20 Reiterated Rating FBR & Co Buy
2016-06-15 Reiterated Rating Morgan Stanley Hold

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Barrett George S Chairman and CEO 0.15%  (518385) CAH / ETN /
Kaufmann Michael C CEO, Pharmaceutical Segment 0.06%  (211849) CAH / MSM /
Casey Donald M Jr. CEO, Medical Segment 0.04%  (146503) BIOD / CAH / WSTC / XRAY /
Morford Craig S Chief Legal/Compliance Officer 0.03%  (109873) CAH / RPM /
Henderson Jeffrey William Chief Financial Officer 0.02%  (67190) CAH / FGEN / HALO / QCOM /
Giacomin Jon L CEO, Pharmaceutical Segment 0.02%  (55048) CAH /
DOWNEY BRUCE 0.01%  (37985) CAH / MNTA /
NOTEBAERT RICHARD C 0.01%  (35778) AEP / AON / CAH /
MORRISON PATRICIA Chief Information Officer 0.01%  (34978) CAH / SPLK /
Stephen Falk T EVP, Gen. Counsel & Corp. Sec. 0.01%  (32455) CAH /
WATKINS CAROLE S Chief HR Officer 0.01%  (31585) CAH /
DARDEN CALVIN 0.01%  (29689) CAH / CCE / TGT /
KENNY GREGORY B 0.01%  (29648) AKS / BGC / CAH / INGR /
Arnold Colleen F. 0.01%  (28515) CAH / IBM /
COX CARRIE SMITH 0.01%  (25687) CAH / CELG / TXN /
FINN JOHN F 0.01%  (21074) CAH / GEF /
KING DAVID P 0.01%  (21044) CAH / LH /
Blake Mark R EVP - Strategy & Corp. Dev. 0.01%  (20409) CAH /
BRITT GLENN 0.01%  (18314) CAH / TWC / XRX /

Comments